Clinical Trials
58 trialsPredicting Disease Progression and/or Recurrence in Cancer
Massachusetts General Hospital
Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc.
IFM/DFCI2009
University Hospital, Toulouse
ROTOR
Novartis
Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice
Pfizer
CerebralEDV
Engeneic Pty Limited
LAANTERN
Monteris Medical
Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors
University of California, San Francisco
Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNB
The First Hospital of Jilin University
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
COMBITEP
Institut Bergonié
BMT-03
University of Illinois at Chicago
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
M.D. Anderson Cancer Center
Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy
Ain Shams University
Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
St. Jude Children's Research Hospital
LAASR
Monteris Medical
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry
Monteris Medical
Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer
Wroclaw Medical University
SLNB After Neoadjuvant Treatment in Node Positive Patients
Clinical Hospital Center Rijeka
DD
University Medical Center Groningen
PATNIC
Norwegian University of Science and Technology
CART-19 for Multiple Myeloma
University of Pennsylvania
Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants
National Taiwan University Hospital
BMT CTN 0702
National Heart, Lung, and Blood Institute (NHLBI)
ELY
Hôpital Cochin
Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers
Mansoura University
SIS
West China Hospital
Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
National Institutes of Health Clinical Center (CC)
Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)
National Heart, Lung, and Blood Institute (NHLBI)
SPECIFY
University Hospital, Montpellier
Salvage Surgery for Patients With Metastatic GIST With Rego
Chang Gung Memorial Hospital
Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
The Role of Protein Tyrosine Kinase 7 (PTK7) in Non-small Cell Lung Cancer
National Taiwan University Hospital
Study on the Role of FDG-PET in Patients With FL at Time of Relapse/Progression
Fondazione Italiana Linfomi - ETS
ZD6474 to Treat Advanced Brain Cancer in Patients
National Institutes of Health Clinical Center (CC)
Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Celgene
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
Mansoura University
A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours
AstraZeneca
PIK-ORL
Centre Leon Berard
Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer Patients
Fudan University
NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
AGC Biologics S.p.A.
NGR018
AGC Biologics S.p.A.
Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer
Huazhong University of Science and Technology
Autologous Redirected RNA Meso-CIR T Cells
University of Pennsylvania
In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?
Ankara Training and Research Hospital
The Roles of Tissue Factor in Malignant Gliomas
Ontario Clinical Oncology Group (OCOG)
Improving Energy Balance in Men With Prostate Cancer
University of Alabama at Birmingham
Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Novartis
p16 and Ki-67 Stainings and Natural Killer (NK) Cells in CIN-II Management
Parc de Salut Mar
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
National Institutes of Health Clinical Center (CC)